Recent developments in pleurodesis for malignant pleural disease
- PMID: 30252207
- DOI: 10.1111/crj.12958
Recent developments in pleurodesis for malignant pleural disease
Abstract
Objective: Metastatic pleural effusion (MPE) is one of the most frequent causes of pleural effusion. The aims of the therapeutic management are palliation of symptoms and improvement in patient's quality of life. The first step is a therapeutic thoracentesis. In case of a recurrent MPE, pleural maneuvers can be used to manage symptoms based on either ambulatory pleural drainage or pleurodesis to prevent fluid accumulation. The aim of this review is to describe recent advances, according to the best available evidence, in the field of pleurodesis for the management of MPE.
Data source and study selection: Three different searches of the most clinically relevant articles and up-to-date results in the field of pleurodesis for the management of MPE were performed using PubMed. Different indexing terms and time restriction were chosen. From these PubMed searches, 322 articles were respectively found. After cross-checking these three lists and the selection of articles published after January 2010 specially dedicated to the management of MPE by pleurodesis, the abstracts of 106 articles were extracted to feed the corpus of this review.
Results and conclusion: Treatment approaches of recurrent MPE should take into account multiple factors in particular patient's life expectancy and preference. If talc is the best sclerosing agent alone or in combination with indwelling pleural catheter which is a promising strategy, the pathophysiology of MPE has to be revisited in order to propose a personalized management targeting intrapleural key molecules involved in the genesis of malignant process.
Keywords: dyspnea; indwelling pleural catheter; malignant effusion; palliation; talc; thoracentesis; thoracoscopy.
© 2018 John Wiley & Sons Ltd.
Similar articles
-
Contemporary best practice in the management of malignant pleural effusion.Ther Adv Respir Dis. 2018 Jan-Dec;12:1753466618785098. doi: 10.1177/1753466618785098. Ther Adv Respir Dis. 2018. PMID: 29952251 Free PMC article. Review.
-
Malignant Pleural Effusion: Still a Long Way to Go.Rev Recent Clin Trials. 2019;14(1):24-30. doi: 10.2174/1574887114666181204105208. Rev Recent Clin Trials. 2019. PMID: 30514193
-
Management of Malignant Pleural Effusions. An Official ATS/STS/STR Clinical Practice Guideline.Am J Respir Crit Care Med. 2018 Oct 1;198(7):839-849. doi: 10.1164/rccm.201807-1415ST. Am J Respir Crit Care Med. 2018. PMID: 30272503
-
Fast pleurodesis combining talc poudrage and indwelling pleural catheter for the management of recurrent malignant pleural effusions.Respir Med Res. 2024 Nov;86:101124. doi: 10.1016/j.resmer.2024.101124. Epub 2024 Jun 22. Respir Med Res. 2024. PMID: 38968680
-
Indwelling pleural catheter versus talc pleurodesis for malignant pleural effusion: a meta-analysis.Clin Exp Metastasis. 2020 Aug;37(4):541-549. doi: 10.1007/s10585-020-10042-2. Epub 2020 Jun 10. Clin Exp Metastasis. 2020. PMID: 32524317
Cited by
-
Cost Comparison of Treatment Alternatives for Pleural Effusion and Ascites from a Payer Perspective: Are There Cost Savings from Indwelling Catheters?J Palliat Med. 2023 Nov;26(11):1510-1520. doi: 10.1089/jpm.2022.0592. Epub 2023 Jun 23. J Palliat Med. 2023. PMID: 37352428 Free PMC article.
-
Patient-derived spheroids and patient-derived organoids simulate evolutions of lung cancer.Heliyon. 2023 Feb 18;9(3):e13829. doi: 10.1016/j.heliyon.2023.e13829. eCollection 2023 Mar. Heliyon. 2023. PMID: 36895411 Free PMC article.
-
Talc pleurodesis versus indwelling pleural catheter among patients with malignant pleural effusion: a meta-analysis of randomized controlled trials.World J Surg Oncol. 2020 Jul 23;18(1):184. doi: 10.1186/s12957-020-01940-6. World J Surg Oncol. 2020. PMID: 32703255 Free PMC article.
-
Acute Oncologic Complications: Clinical-Therapeutic Management in Critical Care and Emergency Departments.Curr Oncol. 2023 Aug 2;30(8):7315-7334. doi: 10.3390/curroncol30080531. Curr Oncol. 2023. PMID: 37623012 Free PMC article. Review.
-
Viscum pleurodesis is as effective as talc pleurodesis and tends to have less adverse effect.Support Care Cancer. 2020 Nov;28(11):5463-5467. doi: 10.1007/s00520-020-05405-0. Epub 2020 Mar 12. Support Care Cancer. 2020. PMID: 32166382 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical